Logo
F

First Wave BioPharma, Inc.

14 employees

First Wave Bio develops medical solutions to address the lack of effective and safe treatments for Inflammatory Bowel Disease (IBD).

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
exocrine pancreatic insufficiency
Recombinant proteins
Health Care
chronic pancreatitis
COVID-19 GI infections
niclosamide
Lipase
pancreatic enzyme replacement therapy
Wellness
Non-sytemic therapies
cystic fibrosis
Medical
immune checkpoint inhibitor colitis

Date founded

2014

Funding rounds raised

Total raised

$2.6M

from 1 investors over 1 rounds

F

First Wave BioPharma, Inc. raised $2.6M on September 6, 2018

Investors: Omega Funds

FAQ